Latest Rare diseases Stories
DURHAM, N.C., Jan. 2, 2015 /PRNewswire/ -- Scioderm, Inc., today announced Robert Ryan, Ph.D., president and chief executive officer, will present a corporate update at the 33rd Annual J.P.
A new study published in Proceedings of the National Academy of Sciences has found that a drug used to treat Lou Gehrig’s disease (ALS) called riluzole can prevent cognitive decline in lab rats, and could lead to effective treatments in humans.
LYNBROOK, N.Y., Dec. 22, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp.
Funds will be used to complete the clinical development program for ZorblisaTM DURHAM, N.C., Dec.
Former head of rare diseases at Genzyme brings a 20-year track record of delivering successful, innovative products to patients throughout the world PHILADELPHIA, Dec.
CALABASAS, Calif., Dec.
MINNEAPOLIS, Dec. 5, 2014 /PRNewswire-USNewswire/ -- Today the Child Neurology Foundation (CNF), named Elizabeth A.
- A poem in which the author retracts something said in an earlier poem.